Powering the Next Wave of Precision Genetic Medicines — Together
We believe in winning together and importantly, winning in our shared mission to help more patients in need.
Our goal is to maximize the potential of our inhaled LNP delivery technology beyond the rare diseases in our pipeline, so that more patients may realize the full benefit of genetic medicines.
Contact our team at [email protected] to explore how our proven inhaled LNP platform can advance your genetic medicine programs.
“Our lipid nanoparticle platform was discovered and built to deliver genetic medicines with precision and efficacy. It has already demonstrated safety and proof of activity in clinical studies for two drug products. ReCode inhaled lipid nanoparticles create treatment options for patients in dire need and even a hope for a cure for patients with cystic fibrosis. I am excited to be part of the ReCode team.”
Vladimir Kharitonov
Chief Technology Officer
Do you want to be on the frontier of a new generation of precision genetic medicines?
Contact us at [email protected]
